RI
DNTH icon

RTW Investments’s Dianthus Therapeutics DNTH Stock Holding History

RTW Investments’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.2M Hold
248,063
– – 0.21% 56
2026
Q1 		$20.8M Buy
+248,063
New +$14.4M 0.21% 60
2025
Q1 		– Sell
-666,667
Closed -$14.5M – 70
2024
Q4 		$14.5M Hold
666,667
– – 0.22% 51
2024
Q3 		$18.3M Hold
666,667
– – 0.26% 47
2024
Q2 		$17.3M Hold
666,667
– – 0.27% 43
2024
Q1 		$20M Buy
+666,667
New +$14.5M 0.3% 47

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

RTW Investments's DNTH Position: Q2 2026 in Review

RTW Investments held its Dianthus Therapeutics (DNTH) position steady in Q2 2026 at 248,063 shares worth $24.2M. The position accounts for 0.21% of the portfolio, ranked #56.

RTW Investments first reported a position in DNTH in Q1 2024 and has held it in 6 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • RTW Investments held 248,063 shares of Dianthus Therapeutics worth $24.2M as of Q2 2026.
  • RTW Investments left its Dianthus Therapeutics share count unchanged in Q2 2026.
  • Dianthus Therapeutics made up 0.21% of RTW Investments's portfolio in Q2 2026, its #56 holding.
  • RTW Investments first reported a position in Dianthus Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.